OSA
ProSomnus, Inc. Common Stock
Delisted
OSA was delisted on the 17th of April, 2024.
About: ProSomnus Inc is a medical device manufacturer. It manufactures precision, mass-customized oral appliance therapy devices to treat obstructive sleep apnea, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus's patented devices are a more comfortable and less invasive alternative to continuous positive airway pressure therapy and lead to more effective and patient-preferred outcomes.
Employees: 136
Price charts implemented using
Lightweight Charts™